Huiqing Hu
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
PEGylated β-Cell-Targeting Exosomes from Mesenchymal Stem Cells Improve β Cell Function and Quantity by Suppressing NRF2-Mediated Ferroptosis.
Journal: International journal of nanomedicine
Published: February 20, 2024
Glycoengineered extracellular vesicles released from antibacterial hydrogel facilitate diabetic wound healing by promoting angiogenesis.
Journal: Journal of extracellular vesicles
Published: February 20, 2024
Mesenchymal stromal cells ameliorate mitochondrial dysfunction in α cells and hyperglucagonemia in type 2 diabetes via SIRT1/FoxO3a signaling.
Journal: Stem cells translational medicine
Published: November 21, 2023
Didymin protects pancreatic beta cells by enhancing mitochondrial function in high-fat diet-induced impaired glucose tolerance.
Journal: Diabetology & metabolic syndrome
Published: October 04, 2023
Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation.
Journal: Lipids in health and disease
Published: August 10, 2023
Retraction Note: Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy.
Journal: Stem cell research & therapy
Published: October 21, 2022
Retraction Note: Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation.
Journal: Stem cell research & therapy
Published: October 08, 2022
Mesenchymal stromal cells ameliorate diabetes-induced muscle atrophy through exosomes by enhancing AMPK/ULK1-mediated autophagy.
Journal: Journal of cachexia, sarcopenia and muscle
Published: June 21, 2022
cGAS-STING activation contributes to podocyte injury in diabetic kidney disease.
Journal: iScience
Published: January 25, 2022
Relationship Between Muscle Cramps and Diabetic Retinopathy in Patients with Type 2 Diabetes.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: December 13, 2021
Mesenchymal stem cell-conditioned medium alleviates high fat-induced hyperglucagonemia via miR-181a-5p and its target PTEN/AKT signaling.
Journal: Molecular and cellular endocrinology
Published: April 15, 2021
Mof acetyltransferase inhibition ameliorates glucose intolerance and islet dysfunction of type 2 diabetes via targeting pancreatic α-cells.
Journal: Molecular and cellular endocrinology
Published: April 06, 2021
Last Updated: 09/26/2026